Key result
Levothyroxine replacement rapidly reverses hypothyroidism-induced Brugada-type ECG changes even at low initial doses.
Why the study?
Severe hypothyroidism has been suggested as a trigger for Brugada-type ECG abnormalities, but the severity of thyroid dysfunction required and its occurrence in non-Asian patients remain unclear.
Does levothyroxine therapy reverse Brugada-type ECG abnormalities in patients with severe hypothyroidism?
Case Report (n=1)
Does levothyroxine therapy reverse Brugada-type ECG abnormalities in patients with severe hypothyroidism?
Severe hypothyroidism can act as a reversible trigger for Brugada-type ECG abnormalities across different genetic backgrounds, and these changes may resolve rapidly even with subtherapeutic levothyroxine replacement.
Answers are grounded in this paper and cite their sources.
Levothyroxine may reverse hypothyroidism-triggered Brugada ECG changes; single case leaves open generalizability and need for prospective confirmation.
Brugada syndrome (BrS) is an inherited disorder that can cause ventricular fibrillation and sudden cardiac death in individuals with otherwise structurally normal hearts. Several provoking factors are known to potentially unmask or exacerbate a typical Brugada ECG pattern in predisposed subjects. Hypothyroidism has been suggested as one of these triggers, but the exact mechanisms underlying this relationship remain poorly understood. Moreover, the severity of thyroid dysfunction beyond which a Brugada-type ECG alteration might be triggered is still unclear. We report the case of a 33-year-old male who displayed a Brugada type 1 ECG pattern and was diagnosed with severe hypothyroidism (TSH > 100 mU/L with undetectable levels of fT4 and fT3). Hormonal replacement therapy with levothyroxine was initiated at increasing doses; serial biochemical and ECG controls were performed, initially every 3 weeks up to 15 weeks and afterward every 3 months. The regression of typical Brugada ECG waveforms could be seen at an early stage, when the patient was still taking a low dose of levothyroxine (37.5 µg/day, i.e., one-fourth of his final requirements of 150 µg/day), and laboratory tests still showed a marked alteration of thyroid hormonal parameters. Hypothyroidism may act as a trigger for Brugada-type ECG abnormalities, but a very severe alteration of the hormonal parameters is necessary to prompt these alterations. In our case, the initiation of replacement therapy with levothyroxine rapidly reversed the ECG modifications, even at a low subtherapeutic dose.
No takes yet. Share an insight, caveat, or question.
Bioletto et al. (2024) conducted a case report in Severe hypothyroidism triggering Brugada-type ECG abnormalities (n=1). Levothyroxine was evaluated on Regression of Brugada-type ECG abnormalities. Initiation of replacement therapy with levothyroxine rapidly reversed Brugada-type ECG modifications triggered by severe hypothyroidism, with early regression seen even at a low subtherapeutic dose of /day.
Synapse has enriched 10 related papers. Consider them for comparative context: